Microbix Biosystems Inc. (TSE:MBX – Get Rating)’s stock price crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$0.42 and traded as low as C$0.38. Microbix Biosystems shares last traded at C$0.39, with a volume of 6,000 shares traded.
Microbix Biosystems Stock Down 2.6 %
The business’s fifty day moving average price is C$0.42 and its 200 day moving average price is C$0.48. The company has a market capitalization of C$52.82 million and a P/E ratio of 19.50. The company has a current ratio of 7.84, a quick ratio of 5.57 and a debt-to-equity ratio of 23.60.
Microbix Biosystems (TSE:MBX – Get Rating) last announced its earnings results on Thursday, December 22nd. The company reported C($0.01) earnings per share (EPS) for the quarter. The company had revenue of C$4.33 million for the quarter, compared to analyst estimates of C$5.10 million. As a group, equities research analysts predict that Microbix Biosystems Inc. will post 0.0404762 earnings per share for the current fiscal year.
Microbix Biosystems Company Profile
Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably test ingredients for immunoassays and quality assessment and proficiency testing controls (QAPs) that support sample collection devices.
Recommended Stories
- Is The Bottom In For Cyber-Security Stocks?
- Union Pacific, Norfolk Southern Pull into Buying Zone
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Receive News & Ratings for Microbix Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbix Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.